Ovid Therapeutics (OVID)'s 30-day implied volatility (IV30) was 68.0% at the close on November 13, 2026, down from 84.2% the day before, against a 52-week range of 48.2% to 131.4%. Its 20-day historical volatility was 98.7%.
Data as of November 13, 2026.